Long-Term Persistence with Injectable Therapy in Relapsing-Remitting Multiple Sclerosis: An 18-Year Observational Cohort Study

Disease modifying therapies (DMTs) reduce the frequency of relapses and accumulation of disability in multiple sclerosis (MS). Long-term persistence with treatment is important to optimize treatment benefit. This long-term, cohort study was conducted at the Calgary MS Clinic. All consenting adults w...

Full description

Saved in:

Bibliographic Details
Published in:	PloS one Vol. 10; no. 4; p. e0123824
Main Authors:	Zhornitsky, Simon, Greenfield, Jamie, Koch, Marcus W., Patten, Scott B., Harris, Colleen, Wall, Winona, Alikhani, Katayoun, Burton, Jodie, Busche, Kevin, Costello, Fiona, Davenport, Jeptha W., Jarvis, Scott E., Lavarato, Dina, Parpal, Helene, Patry, David G., Yeung, Michael, Metz, Luanne M.
Format:	Journal Article
Language:	English
Published:	United States Public Library of Science 13.04.2015 Public Library of Science (PLoS)
Subjects:	Adult Adults Analysis Autoimmune diseases Biological response modifiers Cohort analysis Cohort Studies Copolymer 1 Diabetes Drug dosages Female Footprints Glatiramer Acetate - administration & dosage Hepatitis Humans Injections, Subcutaneous Interferon Interferon beta-1a - administration & dosage Interferon beta-1b - administration & dosage Male Medicine Middle Aged Multiple sclerosis Multiple Sclerosis, Relapsing-Remitting - drug therapy Neurosciences Nurses Observational studies Patients Population Population studies Pregnancy Rank tests Regression analysis Regression models Switches β-Interferon Canada United States > US Calgary Alberta Canada
ISSN:	1932-6203, 1932-6203
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!